Prolysis is an antibacterial drug discovery and development company with new classes of compounds in pre-clinical development. Novel antibacterial drugs are urg...
| Website | http://prolysis.co.uk |
| Revenue | $1.8 million |
| Employees | 2 (0 on RocketReach) |
| Phone | +44 1865 854700 |
| Industry | Biotechnology, Manufacturing, Pharmaceuticals, Pharmaceutical, Healthcare, Health Care |
| Keywords | Antibacterial Drugs, Drug Discovery, Drug Development, Preclinical Development, Novel Antibiotics, Pharmaceutical Research, New Drug Entities, Antimicrobial Agents, Infection Treatment, Pharmaceutical Development, Biotechnology, Drug Pipeline, Clinical Trials, Pharmaceutical Innovation, Medicinal Chemistry, Drug Candidates, Research And Development, Life Sciences |
| Competitors | Amphenol Nexus Technologies, deltatechnologies.com, Pinnacle Solutions Inc, Kappa Computer Systems LLC, Sigma Solutions LLC, Visionary Tech, Alpha Technology Solutions, Evergeneral Trading Corp, THETA LABORATORIES, INC., Gamma Innovations +14 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Prolysis Ltd employee's phone or email?
The Prolysis Ltd annual revenue was $1.8 million in 2026.
The NAICS codes for Prolysis Ltd are [3254, 32, 325].
The SIC codes for Prolysis Ltd are [283, 28].